AACE 26th Annual Scientific & Clinical Congress

All Specialties

test

The Annual Scientific & Clinical Congress, now in its 26th year, will highlight the latest technological and medical advances in endocrinology and practical workshops for attendees to take home to their practices. Superb speakers will cover all aspects of endocrinology, including sessions focusing on tips for a successful practice in today's economic milieu.

Branded Levothyroxine Bests Generic for Hypothyroidism

The Synthroid brand of levothyroxine improved thyroid-stimulating hormone (TSH) levels by a significantly greater margin compared with generic versions of the synthetic T4 (LT4) hormones for patients with hypothyroidism.

Tymlos Provides an Alternative Treatment for Women with Postmenopausal Menopause

At AACE 2017, John Bilezikian, MD, discussed the latest FDA approval of Tymlos for postmenopausal women with osteoporosis and for women who are at high risk for fracture.

Misunderstandings in Identifying and Treating Hypothyroidism

According to Kathleen â€œKittieâ€ Wyne, MD, PhD, The Ohio State University, in the identification and treatment of hypothyroidism, people need to be aware that the symptoms associated with hypothyroidism can be non-specific.

Hypothyroidism: Assessing Rates of Adherence to Levothyroxine

At AACE 2017, Kathleen â€œKittieâ€ Wyne, MD, PhD, The Ohio State University, discussed new data on hypothyroidism. Although hypothyroidism requires lifelong adherence to therapy, compliance still remains challenging.

Diabetes in the Elderly Addressed at AACE Meeting

More than 25% of the US population over the age of 65 has diabetes.

Improving Quality of Care with Electronic Glycemic Management Systems

At AACE 2017, Jagdeesh Ullal, MD, MS, Eastern Virginia Medical School discussed data from his teamâ€™s study that assessed the efficacy of an electronic glycemic management system (eGlycemic Management) management in controlling blood sugars in the hospital setting.